NCCN Pharmacy Updates: New Agents for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting

April 16, 2018

Join Laura Michaud, PharmD, BCOP, FASHP, CMQ from The University of Texas MD Anderson Cancer Center for this webinar in the 2018 NCCN Pharmacy Update Webinar Series on the topic New Agents for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting.

Target Audience

This educational program is designed to meet the educational needs of pharmacists, nurses, nurse practitioners, physician assistants, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Review the rationale behind the choice of antiemetic regimens for highly- and moderately-emetogenic chemotherapy based on chemotherapy agent, dose, schedule and route of administration, and individual patient characteristics.
  • Describe dosing, monitoring, and adverse events associated with antiemetic agents and regimens.
  • Discuss strategies for evaluating response to antiemetic regimens and preventing CINV in subsequent cycles if breakthrough CINV was uncontrolled.
Additional information
Supporters: 

This activity is supported by educational grants from:

  • AstraZeneca
  • Celgene Corporation
  • Lilly
  • Novartis Pharmaceuticals Corporation
  • Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
  • Prometheus Laboratories Inc.
  • Takeda Oncology

This activity is supported by an independent educational grant from Incyte.

This activity is supported by an unrestricted educational grant from Gilead Sciences, Medical Affairs.

This activity is supported by educational funding provided by Amgen.

Course summary
Available credit: 
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Course opens: 
12/18/2017
Course expires: 
06/10/2018
Event starts: 
04/16/2018 - 4:00pm EDT
Event ends: 
04/16/2018 - 5:00pm EDT
Cost:
$0.00

Laura Michaud, PharmD, BCOP, FASHP, CMQ
The University of Texas MD Anderson Cancer Center

 

Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Physicians
National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NCCN designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.0 hour of Category I credit for completing this activity.

Nurses
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

NCCN designates this educational activity for a maximum of 1.0 contact hour.

Pharmacists

National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

NCCN designates this knowledge-based continuing education activity for 1.0 contact hour (0.1 CEUs) of continuing education credit. UAN: 0836-0000-18-064-L01-P

Available Credit

  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing